Albany, NY, April 12, 2016 -- Transparency Market Research (TMR) has announced the publication of a new market study on the cell culture market. According to the research study, the global cell culture market is estimated to expand at a CAGR of 7.1% from the period of 2014 to 2022, reaching US$11.3 bn from its 2013 value of US$6.1 bn.The report is titled “Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.” It contains useful information on the global cell culture market, its segmentation, applications, market drivers and constraints, as well as market opportunities for cell culture.
Get a Free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
The report segments the global cell culture market into the cell culture instruments market and the cell culture consumables market. The cell culture instruments market includes instruments such as pipetting instruments, incubators, biosafety cabinets, culture systems, cryostorage equipment, and roller bottle equipment, while the market for cell culture consumables comprises reagents, sera, and media. Furthermore, the media segment is categorized into lysogeny broth, chemically defined media, protein-free media, classical media, serum-free media, and specialty media.
The report also segments the global cell culture market by geography, analyzing the North America, the Asia Pacific and Europe regional markets.
The report highlights the strategies used by major competitors, industry trends, a clear illustration of the growth trajectory of the market, and an updated analysis of the technological improvements in the industry. It also contains several infographics depicting the impact analysis and SWOT analysis of the cell culture’s major industry segments. The report presents the competitive landscape in a clear manner, along with the key product segments.
Research Report with ToC& Free Analysis: http://www.transparencymarketresearch.com/cell-culture-market.html
The increased demand for biopharmaceuticals and artificial organs has been responsible for a rise in the global cell culture market in the past and is expected to continue to impact the cell culture market positively in the forecast period. Cell culture is also increasingly used for drug discovery, presenting a rich market for cell culture market players. Technical innovations and advancements in design and operation of various instruments drives the market for cell culture instruments. Moreover, the use of cell culture media to study genetic engineering, cellular structures, and for stem cell research is responsible for the expected growth of the cell culture consumables market for the forecast period.
Usage of animal sources is anticipated to raise ethical concerns and hamper the growth of the cell culture market. Strictly enforced high standards set by government regulatory bodies for advanced cell culture production are anticipated to hamper the growth of the cell culture market in the near future.
Browse Market Research Blog:http://www.tmrblog.com/2015/10/cell-culture-market.html
Some of the key companies mentioned in the report are VWR International LLC, Thermo Fisher Scientific Inc., Lonza Group Ltd., Dickinson & Co., GE Healthcare, EMD Millipore, Becton, Corning Life Sciences B.V., Wheaton Industries Inc. and PromoCell GmbH, Sigma-Aldrich Co. LLC.
The global cell culture market is segmented as:
Cell Culture Consumables Market - Products
- Media
- Sera
- Reagents
Cell Culture Instruments Market – Products
- Culture Systems
- Incubators
- Pipetting Instruments
- Roller Bottle Equipment
- Biosafety Cabinets
- Cryostorage Equipment
- Others
Major regions analyzed under this research report are:
- Europe
- North America
- Asia Pacific
- Rest of the World
Other Trending Reports by TMR:
- Cell Culture Media, Sera, and Reagents Market: http://www.transparencymarketresearch.com/cell-culture-media-sera-reagents-market.html
- Cell Culture Protein Surface Coatings Market: http://www.transparencymarketresearch.com/cell-culture-protein-surface-coatings-market.html
- Stem Cells Market:http://www.transparencymarketresearch.com/stem-cells-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



